nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone decanoate—CYP19A1—Paclitaxel—ovarian cancer	0.266	1	CbGbCtD
Nandrolone decanoate—CYP19A1—follicular fluid—ovarian cancer	0.0988	0.271	CbGeAlD
Nandrolone decanoate—CYP19A1—corpus luteum—ovarian cancer	0.0569	0.156	CbGeAlD
Nandrolone decanoate—CYP19A1—ovarian follicle—ovarian cancer	0.0445	0.122	CbGeAlD
Nandrolone decanoate—Testicular atrophy—Chlorambucil—ovarian cancer	0.0286	0.179	CcSEcCtD
Nandrolone decanoate—MAOB—Alpha-synuclein signaling—KLK6—ovarian cancer	0.018	0.0974	CbGpPWpGaD
Nandrolone decanoate—AR—oviduct—ovarian cancer	0.0173	0.0475	CbGeAlD
Nandrolone decanoate—AR—Regulation of Androgen receptor activity—SPDEF—ovarian cancer	0.00833	0.0451	CbGpPWpGaD
Nandrolone decanoate—Local reaction—Melphalan—ovarian cancer	0.00654	0.0409	CcSEcCtD
Nandrolone decanoate—MAOB—Dopamine metabolism—SOD1—ovarian cancer	0.00624	0.0338	CbGpPWpGaD
Nandrolone decanoate—MAOB—myometrium—ovarian cancer	0.00589	0.0162	CbGeAlD
Nandrolone decanoate—Oligospermia—Epirubicin—ovarian cancer	0.0058	0.0363	CcSEcCtD
Nandrolone decanoate—Local reaction—Vinorelbine—ovarian cancer	0.00571	0.0357	CcSEcCtD
Nandrolone decanoate—MAOB—embryo—ovarian cancer	0.00566	0.0155	CbGeAlD
Nandrolone decanoate—AR—myometrium—ovarian cancer	0.00554	0.0152	CbGeAlD
Nandrolone decanoate—Oligospermia—Doxorubicin—ovarian cancer	0.00537	0.0336	CcSEcCtD
Nandrolone decanoate—MAOA—myometrium—ovarian cancer	0.00502	0.0138	CbGeAlD
Nandrolone decanoate—MAOB—Alpha-synuclein signaling—PARK2—ovarian cancer	0.005	0.0271	CbGpPWpGaD
Nandrolone decanoate—AR—Nuclear Receptors—NR5A1—ovarian cancer	0.00499	0.027	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Ovarian Infertility Genes—NR5A1—ovarian cancer	0.00493	0.0267	CbGpPWpGaD
Nandrolone decanoate—Hoarseness—Paclitaxel—ovarian cancer	0.00484	0.0302	CcSEcCtD
Nandrolone decanoate—MAOA—embryo—ovarian cancer	0.00483	0.0133	CbGeAlD
Nandrolone decanoate—CYP19A1—Ovarian Infertility Genes—INHA—ovarian cancer	0.00479	0.026	CbGpPWpGaD
Nandrolone decanoate—Amenorrhoea—Chlorambucil—ovarian cancer	0.00473	0.0295	CcSEcCtD
Nandrolone decanoate—MAOB—uterine cervix—ovarian cancer	0.00458	0.0126	CbGeAlD
Nandrolone decanoate—Azoospermia—Epirubicin—ovarian cancer	0.00452	0.0282	CcSEcCtD
Nandrolone decanoate—CYP19A1—endometrium—ovarian cancer	0.0044	0.0121	CbGeAlD
Nandrolone decanoate—MAOB—decidua—ovarian cancer	0.00437	0.012	CbGeAlD
Nandrolone decanoate—AR—epithelium—ovarian cancer	0.00435	0.0119	CbGeAlD
Nandrolone decanoate—AR—uterine cervix—ovarian cancer	0.00431	0.0118	CbGeAlD
Nandrolone decanoate—Azoospermia—Doxorubicin—ovarian cancer	0.00418	0.0261	CcSEcCtD
Nandrolone decanoate—MAOB—endometrium—ovarian cancer	0.00415	0.0114	CbGeAlD
Nandrolone decanoate—Amenorrhoea—Melphalan—ovarian cancer	0.00412	0.0258	CcSEcCtD
Nandrolone decanoate—AR—decidua—ovarian cancer	0.00411	0.0113	CbGeAlD
Nandrolone decanoate—CYP19A1—gonad—ovarian cancer	0.00409	0.0112	CbGeAlD
Nandrolone decanoate—CYP19A1—uterus—ovarian cancer	0.00406	0.0111	CbGeAlD
Nandrolone decanoate—CYP19A1—FSH signaling pathway—AREG—ovarian cancer	0.00405	0.022	CbGpPWpGaD
Nandrolone decanoate—AR—Nuclear Receptor transcription pathway—NR5A1—ovarian cancer	0.00394	0.0214	CbGpPWpGaD
Nandrolone decanoate—MAOA—Dopamine metabolism—SOD1—ovarian cancer	0.00392	0.0212	CbGpPWpGaD
Nandrolone decanoate—MAOA—uterine cervix—ovarian cancer	0.00391	0.0107	CbGeAlD
Nandrolone decanoate—AR—endometrium—ovarian cancer	0.0039	0.0107	CbGeAlD
Nandrolone decanoate—MAOB—uterus—ovarian cancer	0.00382	0.0105	CbGeAlD
Nandrolone decanoate—MAOA—decidua—ovarian cancer	0.00373	0.0102	CbGeAlD
Nandrolone decanoate—CYP19A1—female reproductive system—ovarian cancer	0.00365	0.01	CbGeAlD
Nandrolone decanoate—AR—gonad—ovarian cancer	0.00362	0.00992	CbGeAlD
Nandrolone decanoate—AR—uterus—ovarian cancer	0.00359	0.00985	CbGeAlD
Nandrolone decanoate—MAOA—endometrium—ovarian cancer	0.00354	0.0097	CbGeAlD
Nandrolone decanoate—MAOB—female reproductive system—ovarian cancer	0.00343	0.00942	CbGeAlD
Nandrolone decanoate—CYP19A1—female gonad—ovarian cancer	0.00332	0.00911	CbGeAlD
Nandrolone decanoate—Ethynodiol—PGR—ovarian cancer	0.00329	0.133	CrCbGaD
Nandrolone decanoate—MAOA—uterus—ovarian cancer	0.00326	0.00894	CbGeAlD
Nandrolone decanoate—AR—female reproductive system—ovarian cancer	0.00323	0.00886	CbGeAlD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—BCL9—ovarian cancer	0.00315	0.017	CbGpPWpGaD
Nandrolone decanoate—MAOB—female gonad—ovarian cancer	0.00312	0.00857	CbGeAlD
Nandrolone decanoate—MAOB—vagina—ovarian cancer	0.00311	0.00852	CbGeAlD
Nandrolone decanoate—Norelgestromin—PGR—ovarian cancer	0.0031	0.126	CrCbGaD
Nandrolone decanoate—CYP19A1—testis—ovarian cancer	0.00294	0.00808	CbGeAlD
Nandrolone decanoate—AR—female gonad—ovarian cancer	0.00294	0.00806	CbGeAlD
Nandrolone decanoate—MAOA—female reproductive system—ovarian cancer	0.00293	0.00804	CbGeAlD
Nandrolone decanoate—AR—vagina—ovarian cancer	0.00292	0.00801	CbGeAlD
Nandrolone decanoate—Furunculosis—Epirubicin—ovarian cancer	0.00286	0.0179	CcSEcCtD
Nandrolone decanoate—Norgestimate—PGR—ovarian cancer	0.0028	0.113	CrCbGaD
Nandrolone decanoate—MAOB—testis—ovarian cancer	0.00277	0.0076	CbGeAlD
Nandrolone decanoate—CYP19A1—Endogenous sterols—CYP1B1—ovarian cancer	0.00272	0.0147	CbGpPWpGaD
Nandrolone decanoate—MAOA—female gonad—ovarian cancer	0.00267	0.00731	CbGeAlD
Nandrolone decanoate—MAOA—vagina—ovarian cancer	0.00265	0.00727	CbGeAlD
Nandrolone decanoate—Furunculosis—Doxorubicin—ovarian cancer	0.00265	0.0165	CcSEcCtD
Nandrolone decanoate—AR—testis—ovarian cancer	0.00261	0.00715	CbGeAlD
Nandrolone decanoate—CYP19A1—Ovarian Infertility Genes—MLH1—ovarian cancer	0.00259	0.014	CbGpPWpGaD
Nandrolone decanoate—Dysphonia—Paclitaxel—ovarian cancer	0.00259	0.0162	CcSEcCtD
Nandrolone decanoate—MAOB—Tryptophan metabolism—CYP1B1—ovarian cancer	0.00255	0.0138	CbGpPWpGaD
Nandrolone decanoate—AR—Nuclear Receptors—PGR—ovarian cancer	0.00248	0.0135	CbGpPWpGaD
Nandrolone decanoate—Furuncle—Epirubicin—ovarian cancer	0.00248	0.0155	CcSEcCtD
Nandrolone decanoate—Nausea—Altretamine—ovarian cancer	0.00248	0.0155	CcSEcCtD
Nandrolone decanoate—CYP19A1—Ovarian Infertility Genes—PGR—ovarian cancer	0.00245	0.0133	CbGpPWpGaD
Nandrolone decanoate—Etonogestrel—PGR—ovarian cancer	0.00242	0.0978	CrCbGaD
Nandrolone decanoate—MAOA—testis—ovarian cancer	0.00236	0.00648	CbGeAlD
Nandrolone decanoate—MAOA—Melatonin metabolism and effects—CYP1B1—ovarian cancer	0.00231	0.0125	CbGpPWpGaD
Nandrolone decanoate—Furuncle—Doxorubicin—ovarian cancer	0.00229	0.0143	CcSEcCtD
Nandrolone decanoate—Jaundice—Chlorambucil—ovarian cancer	0.00226	0.0142	CcSEcCtD
Nandrolone decanoate—Local reaction—Epirubicin—ovarian cancer	0.0022	0.0137	CcSEcCtD
Nandrolone decanoate—CYP19A1—lymph node—ovarian cancer	0.00213	0.00585	CbGeAlD
Nandrolone decanoate—Ethynodiol—ESR1—ovarian cancer	0.00208	0.0839	CrCbGaD
Nandrolone decanoate—Amenorrhoea—Docetaxel—ovarian cancer	0.00205	0.0128	CcSEcCtD
Nandrolone decanoate—Local reaction—Doxorubicin—ovarian cancer	0.00203	0.0127	CcSEcCtD
Nandrolone decanoate—Fluid retention—Paclitaxel—ovarian cancer	0.00202	0.0126	CcSEcCtD
Nandrolone decanoate—MAOB—lymph node—ovarian cancer	0.00201	0.00551	CbGeAlD
Nandrolone decanoate—MAOA—Oxidative Stress—SOD1—ovarian cancer	0.00201	0.0109	CbGpPWpGaD
Nandrolone decanoate—Jaundice—Melphalan—ovarian cancer	0.00197	0.0123	CcSEcCtD
Nandrolone decanoate—AR—Nuclear Receptor transcription pathway—PGR—ovarian cancer	0.00196	0.0106	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Ovarian Infertility Genes—CCND2—ovarian cancer	0.00196	0.0106	CbGpPWpGaD
Nandrolone decanoate—AR—Notch-mediated HES/HEY network—PARP1—ovarian cancer	0.00195	0.0106	CbGpPWpGaD
Nandrolone decanoate—AR—lymph node—ovarian cancer	0.00189	0.00518	CbGeAlD
Nandrolone decanoate—MAOA—Oxidative Stress—SOD2—ovarian cancer	0.00181	0.00979	CbGpPWpGaD
Nandrolone decanoate—Seborrhoeic dermatitis—Epirubicin—ovarian cancer	0.00178	0.0112	CcSEcCtD
Nandrolone decanoate—AR—FOXA1 transcription factor network—BRCA1—ovarian cancer	0.00177	0.00957	CbGpPWpGaD
Nandrolone decanoate—Norgestimate—ESR1—ovarian cancer	0.00176	0.0714	CrCbGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—BARD1—ovarian cancer	0.00176	0.00953	CbGpPWpGaD
Nandrolone decanoate—MAOA—lymph node—ovarian cancer	0.00171	0.0047	CbGeAlD
Nandrolone decanoate—Fluid retention—Docetaxel—ovarian cancer	0.00171	0.0107	CcSEcCtD
Nandrolone decanoate—Levonorgestrel—PGR—ovarian cancer	0.00171	0.0692	CrCbGaD
Nandrolone decanoate—Hyperlipidaemia—Epirubicin—ovarian cancer	0.00169	0.0105	CcSEcCtD
Nandrolone decanoate—AR—FOXA1 transcription factor network—SOD1—ovarian cancer	0.00167	0.00907	CbGpPWpGaD
Nandrolone decanoate—Mediastinal disorder—Topotecan—ovarian cancer	0.00167	0.0105	CcSEcCtD
Nandrolone decanoate—MAOB—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.00167	0.00905	CbGpPWpGaD
Nandrolone decanoate—Seborrhoeic dermatitis—Doxorubicin—ovarian cancer	0.00165	0.0103	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Melphalan—ovarian cancer	0.00164	0.0102	CcSEcCtD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CD82—ovarian cancer	0.00164	0.00886	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—ATF3—ovarian cancer	0.00158	0.00854	CbGpPWpGaD
Nandrolone decanoate—Hyperlipidaemia—Doxorubicin—ovarian cancer	0.00156	0.00976	CcSEcCtD
Nandrolone decanoate—CYP19A1—Tryptophan metabolism—CYP1B1—ovarian cancer	0.00156	0.00845	CbGpPWpGaD
Nandrolone decanoate—Etonogestrel—ESR1—ovarian cancer	0.00153	0.0617	CrCbGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—BARD1—ovarian cancer	0.00151	0.0082	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—SMARCA4—ovarian cancer	0.0015	0.00811	CbGpPWpGaD
Nandrolone decanoate—Dysphonia—Epirubicin—ovarian cancer	0.00148	0.00924	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Vinorelbine—ovarian cancer	0.00143	0.00895	CcSEcCtD
Nandrolone decanoate—Norethindrone—PGR—ovarian cancer	0.00139	0.0561	CrCbGaD
Nandrolone decanoate—Amenorrhoea—Epirubicin—ovarian cancer	0.00138	0.00865	CcSEcCtD
Nandrolone decanoate—Dysphonia—Doxorubicin—ovarian cancer	0.00137	0.00855	CcSEcCtD
Nandrolone decanoate—AR—Coregulation of Androgen receptor activity—BRCA1—ovarian cancer	0.00136	0.00737	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TOP1—ovarian cancer	0.00133	0.00723	CbGpPWpGaD
Nandrolone decanoate—AR—Nuclear Receptors—ESR1—ovarian cancer	0.00133	0.00719	CbGpPWpGaD
Nandrolone decanoate—Oedema—Melphalan—ovarian cancer	0.00129	0.00807	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Doxorubicin—ovarian cancer	0.00128	0.00801	CcSEcCtD
Nandrolone decanoate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.00126	0.00683	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.00124	0.00674	CbGpPWpGaD
Nandrolone decanoate—Hypertension—Vinorelbine—ovarian cancer	0.00119	0.00746	CcSEcCtD
Nandrolone decanoate—AR—FOXA1 transcription factor network—ESR1—ovarian cancer	0.00118	0.00639	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Chlorambucil—ovarian cancer	0.00118	0.00736	CcSEcCtD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—NSF—ovarian cancer	0.00117	0.00632	CbGpPWpGaD
Nandrolone decanoate—Fluid retention—Epirubicin—ovarian cancer	0.00115	0.00722	CcSEcCtD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND2—ovarian cancer	0.0011	0.00593	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—FSH signaling pathway—MTOR—ovarian cancer	0.00109	0.00589	CbGpPWpGaD
Nandrolone decanoate—Levonorgestrel—ESR1—ovarian cancer	0.00108	0.0437	CrCbGaD
Nandrolone decanoate—Fluid retention—Doxorubicin—ovarian cancer	0.00107	0.00668	CcSEcCtD
Nandrolone decanoate—MAOA—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.00105	0.00568	CbGpPWpGaD
Nandrolone decanoate—AR—Nuclear Receptor transcription pathway—ESR1—ovarian cancer	0.00105	0.00568	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Chlorambucil—ovarian cancer	0.00105	0.00655	CcSEcCtD
Nandrolone decanoate—Urticaria—Topotecan—ovarian cancer	0.00105	0.00655	CcSEcCtD
Nandrolone decanoate—Urticaria—Melphalan—ovarian cancer	0.00103	0.00641	CcSEcCtD
Nandrolone decanoate—CYP19A1—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.00102	0.00554	CbGpPWpGaD
Nandrolone decanoate—Hepatic function abnormal—Epirubicin—ovarian cancer	0.00101	0.00631	CcSEcCtD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—BRCA1—ovarian cancer	0.00101	0.00545	CbGpPWpGaD
Nandrolone decanoate—Jaundice—Docetaxel—ovarian cancer	0.000983	0.00615	CcSEcCtD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—MSH2—ovarian cancer	0.000964	0.00522	CbGpPWpGaD
Nandrolone decanoate—Mediastinal disorder—Paclitaxel—ovarian cancer	0.000963	0.00602	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.000935	0.00584	CcSEcCtD
Nandrolone decanoate—Pruritus—Topotecan—ovarian cancer	0.000933	0.00583	CcSEcCtD
Nandrolone decanoate—Pruritus—Melphalan—ovarian cancer	0.000914	0.00571	CcSEcCtD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—SMARCA4—ovarian cancer	0.000901	0.00488	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Vinorelbine—ovarian cancer	0.000896	0.0056	CcSEcCtD
Nandrolone decanoate—MAOA—Neuronal System—NSF—ovarian cancer	0.000893	0.00484	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Ovarian Infertility Genes—CDKN1B—ovarian cancer	0.00089	0.00482	CbGpPWpGaD
Nandrolone decanoate—MAOB—Biological oxidations—CYP1B1—ovarian cancer	0.000888	0.00481	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—CCNE1—ovarian cancer	0.000881	0.00477	CbGpPWpGaD
Nandrolone decanoate—Nausea—Chlorambucil—ovarian cancer	0.00088	0.0055	CcSEcCtD
Nandrolone decanoate—AR—Nongenotropic Androgen signaling—MAPK3—ovarian cancer	0.000835	0.00452	CbGpPWpGaD
Nandrolone decanoate—Rash—Topotecan—ovarian cancer	0.000832	0.0052	CcSEcCtD
Nandrolone decanoate—Dermatitis—Topotecan—ovarian cancer	0.000831	0.00519	CcSEcCtD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—MSH2—ovarian cancer	0.00083	0.0045	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—ovarian cancer	0.000821	0.00445	CbGpPWpGaD
Nandrolone decanoate—Mediastinal disorder—Docetaxel—ovarian cancer	0.000816	0.0051	CcSEcCtD
Nandrolone decanoate—Rash—Melphalan—ovarian cancer	0.000814	0.00509	CcSEcCtD
Nandrolone decanoate—Dermatitis—Melphalan—ovarian cancer	0.000814	0.00509	CcSEcCtD
Nandrolone decanoate—Progesterone—PGR—ovarian cancer	0.000808	0.0327	CrCbGaD
Nandrolone decanoate—Hypertension—Paclitaxel—ovarian cancer	0.000803	0.00502	CcSEcCtD
Nandrolone decanoate—CYP19A1—FSH signaling pathway—MAPK3—ovarian cancer	0.000803	0.00435	CbGpPWpGaD
Nandrolone decanoate—AR—FOXA1 transcription factor network—CDKN1B—ovarian cancer	0.000802	0.00435	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Vinorelbine—ovarian cancer	0.000798	0.00499	CcSEcCtD
Nandrolone decanoate—AR—Nongenotropic Androgen signaling—MAPK1—ovarian cancer	0.000795	0.0043	CbGpPWpGaD
Nandrolone decanoate—Nausea—Topotecan—ovarian cancer	0.000784	0.0049	CcSEcCtD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—SMARCA4—ovarian cancer	0.000775	0.0042	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—GADD45A—ovarian cancer	0.000769	0.00417	CbGpPWpGaD
Nandrolone decanoate—Nausea—Melphalan—ovarian cancer	0.000767	0.0048	CcSEcCtD
Nandrolone decanoate—CYP19A1—FSH signaling pathway—MAPK1—ovarian cancer	0.000764	0.00414	CbGpPWpGaD
Nandrolone decanoate—AR—Notch-mediated HES/HEY network—CDKN1B—ovarian cancer	0.000761	0.00412	CbGpPWpGaD
Nandrolone decanoate—Oedema—Paclitaxel—ovarian cancer	0.000759	0.00474	CcSEcCtD
Nandrolone decanoate—Progesterone—CYP1B1—ovarian cancer	0.000755	0.0305	CrCbGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—ovarian cancer	0.000724	0.00392	CbGpPWpGaD
Nandrolone decanoate—Testosterone—CYP1B1—ovarian cancer	0.000714	0.0289	CrCbGaD
Nandrolone decanoate—Rash—Vinorelbine—ovarian cancer	0.000712	0.00445	CcSEcCtD
Nandrolone decanoate—Dermatitis—Vinorelbine—ovarian cancer	0.000711	0.00444	CcSEcCtD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—CHEK2—ovarian cancer	0.000703	0.00381	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—CAV1—ovarian cancer	0.000697	0.00378	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—ovarian cancer	0.000691	0.00375	CbGpPWpGaD
Nandrolone decanoate—AR—Nongenotropic Androgen signaling—PIK3CA—ovarian cancer	0.000689	0.00374	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—NR5A1—ovarian cancer	0.000681	0.00369	CbGpPWpGaD
Nandrolone decanoate—Hypertension—Docetaxel—ovarian cancer	0.000681	0.00425	CcSEcCtD
Nandrolone decanoate—Nausea—Vinorelbine—ovarian cancer	0.00067	0.00419	CcSEcCtD
Nandrolone decanoate—Jaundice—Epirubicin—ovarian cancer	0.000663	0.00415	CcSEcCtD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—GADD45A—ovarian cancer	0.000662	0.00359	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—BRCA1—ovarian cancer	0.000659	0.00357	CbGpPWpGaD
Nandrolone decanoate—Oedema—Docetaxel—ovarian cancer	0.000643	0.00402	CcSEcCtD
Nandrolone decanoate—AR—Nongenotropic Androgen signaling—HRAS—ovarian cancer	0.000638	0.00346	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	0.000637	0.00345	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—ovarian cancer	0.000636	0.00345	CbGpPWpGaD
Nandrolone decanoate—AR—Notch-mediated HES/HEY network—STAT3—ovarian cancer	0.000627	0.00339	CbGpPWpGaD
Nandrolone decanoate—Jaundice—Doxorubicin—ovarian cancer	0.000614	0.00384	CcSEcCtD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—ovarian cancer	0.000613	0.00332	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—CHEK2—ovarian cancer	0.000605	0.00328	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Paclitaxel—ovarian cancer	0.000603	0.00377	CcSEcCtD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—BRCA2—ovarian cancer	0.000596	0.00323	CbGpPWpGaD
Nandrolone decanoate—AR—Coregulation of Androgen receptor activity—CCND1—ovarian cancer	0.000589	0.00319	CbGpPWpGaD
Nandrolone decanoate—AR—Coregulation of Androgen receptor activity—CTNNB1—ovarian cancer	0.000583	0.00316	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	0.000583	0.00316	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—BRCA1—ovarian cancer	0.000567	0.00307	CbGpPWpGaD
Nandrolone decanoate—AR—Nongenotropic Androgen signaling—AKT1—ovarian cancer	0.000563	0.00305	CbGpPWpGaD
Nandrolone decanoate—MAOA—Biological oxidations—CYP1B1—ovarian cancer	0.000557	0.00302	CbGpPWpGaD
Nandrolone decanoate—Mediastinal disorder—Epirubicin—ovarian cancer	0.00055	0.00344	CcSEcCtD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	0.000546	0.00296	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—CYP1B1—ovarian cancer	0.000543	0.00294	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—FSH signaling pathway—AKT1—ovarian cancer	0.000541	0.00293	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—NME2—ovarian cancer	0.000541	0.00293	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Paclitaxel—ovarian cancer	0.000537	0.00336	CcSEcCtD
Nandrolone decanoate—CYP19A1—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000536	0.0029	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—ovarian cancer	0.000513	0.00278	CbGpPWpGaD
Nandrolone decanoate—Progesterone—ESR1—ovarian cancer	0.00051	0.0206	CrCbGaD
Nandrolone decanoate—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000509	0.00318	CcSEcCtD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—ovarian cancer	0.000509	0.00276	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	0.000494	0.00267	CbGpPWpGaD
Nandrolone decanoate—Rash—Paclitaxel—ovarian cancer	0.000479	0.00299	CcSEcCtD
Nandrolone decanoate—Dermatitis—Paclitaxel—ovarian cancer	0.000478	0.00299	CcSEcCtD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	0.000478	0.00259	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	0.000478	0.00259	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—ovarian cancer	0.000474	0.00257	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—ovarian cancer	0.00047	0.00254	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	0.00047	0.00254	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—ovarian cancer	0.00046	0.00249	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—WDR77—ovarian cancer	0.00046	0.00249	CbGpPWpGaD
Nandrolone decanoate—Hypertension—Epirubicin—ovarian cancer	0.000459	0.00287	CcSEcCtD
Nandrolone decanoate—Pruritus—Docetaxel—ovarian cancer	0.000455	0.00284	CcSEcCtD
Nandrolone decanoate—Nausea—Paclitaxel—ovarian cancer	0.000451	0.00282	CcSEcCtD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—ESR1—ovarian cancer	0.00044	0.00238	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—CCND1—ovarian cancer	0.000436	0.00236	CbGpPWpGaD
Nandrolone decanoate—Oedema—Epirubicin—ovarian cancer	0.000434	0.00271	CcSEcCtD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—CTNNB1—ovarian cancer	0.000431	0.00234	CbGpPWpGaD
Nandrolone decanoate—Hypertension—Doxorubicin—ovarian cancer	0.000425	0.00265	CcSEcCtD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—PTEN—ovarian cancer	0.00042	0.00228	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000419	0.00227	CbGpPWpGaD
Nandrolone decanoate—Rash—Docetaxel—ovarian cancer	0.000406	0.00254	CcSEcCtD
Nandrolone decanoate—Dermatitis—Docetaxel—ovarian cancer	0.000405	0.00253	CcSEcCtD
Nandrolone decanoate—Oedema—Doxorubicin—ovarian cancer	0.000402	0.00251	CcSEcCtD
Nandrolone decanoate—AR—Generic Transcription Pathway—YAP1—ovarian cancer	0.000388	0.0021	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—CDH1—ovarian cancer	0.000383	0.00207	CbGpPWpGaD
Nandrolone decanoate—Nausea—Docetaxel—ovarian cancer	0.000382	0.00239	CcSEcCtD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—ovarian cancer	0.00038	0.00206	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—ESR1—ovarian cancer	0.000379	0.00205	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—ovarian cancer	0.000377	0.00204	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—STAT3—ovarian cancer	0.000376	0.00204	CbGpPWpGaD
Nandrolone decanoate—Norethindrone—ABCB1—ovarian cancer	0.000372	0.015	CrCbGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	0.000365	0.00198	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—TTF1—ovarian cancer	0.000361	0.00196	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYTB—ovarian cancer	0.000349	0.00189	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Epirubicin—ovarian cancer	0.000345	0.00215	CcSEcCtD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	0.000345	0.00187	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—EGFR—ovarian cancer	0.000342	0.00185	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NME2—ovarian cancer	0.00034	0.00184	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—PGR—ovarian cancer	0.000339	0.00184	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NME2—ovarian cancer	0.000331	0.00179	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—CDH1—ovarian cancer	0.000329	0.00178	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—NR5A1—ovarian cancer	0.000328	0.00178	CbGpPWpGaD
Nandrolone decanoate—AR—Coregulation of Androgen receptor activity—AKT1—ovarian cancer	0.000328	0.00178	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Doxorubicin—ovarian cancer	0.000319	0.00199	CcSEcCtD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—MTOR—ovarian cancer	0.000319	0.00173	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—PARP1—ovarian cancer	0.000315	0.00171	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Epirubicin—ovarian cancer	0.000307	0.00192	CcSEcCtD
Nandrolone decanoate—MAOB—Metabolism—PPP1CC—ovarian cancer	0.000305	0.00165	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—BRIP1—ovarian cancer	0.000305	0.00165	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.000298	0.00162	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—CASP3—ovarian cancer	0.000293	0.00159	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—CASP3—ovarian cancer	0.000286	0.00155	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—CCND1—ovarian cancer	0.000285	0.00155	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Doxorubicin—ovarian cancer	0.000284	0.00178	CcSEcCtD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—CTNNB1—ovarian cancer	0.000283	0.00153	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000281	0.00152	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—PTEN—ovarian cancer	0.000275	0.00149	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.000275	0.00149	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—MTOR—ovarian cancer	0.000274	0.00149	CbGpPWpGaD
Nandrolone decanoate—Rash—Epirubicin—ovarian cancer	0.000274	0.00171	CcSEcCtD
Nandrolone decanoate—Dermatitis—Epirubicin—ovarian cancer	0.000273	0.00171	CcSEcCtD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	0.000268	0.00145	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.000263	0.00143	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—ovarian cancer	0.000261	0.00142	CbGpPWpGaD
Nandrolone decanoate—Nausea—Epirubicin—ovarian cancer	0.000258	0.00161	CcSEcCtD
Nandrolone decanoate—Rash—Doxorubicin—ovarian cancer	0.000253	0.00158	CcSEcCtD
Nandrolone decanoate—Dermatitis—Doxorubicin—ovarian cancer	0.000253	0.00158	CcSEcCtD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—ovarian cancer	0.000252	0.00137	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—CASP3—ovarian cancer	0.000252	0.00136	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—VEGFA—ovarian cancer	0.000249	0.00135	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	0.000248	0.00134	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—ovarian cancer	0.000246	0.00133	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—ovarian cancer	0.000243	0.00132	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	0.000243	0.00132	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.000243	0.00132	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.000242	0.00131	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—AKT1—ovarian cancer	0.000242	0.00131	CbGpPWpGaD
Nandrolone decanoate—Nausea—Doxorubicin—ovarian cancer	0.000238	0.00149	CcSEcCtD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—ovarian cancer	0.000237	0.00128	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	0.000236	0.00128	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	0.000234	0.00127	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000229	0.00124	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—MYC—ovarian cancer	0.000229	0.00124	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	0.000228	0.00124	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—MAPK1—ovarian cancer	0.000224	0.00121	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—EGFR—ovarian cancer	0.000224	0.00121	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYTB—ovarian cancer	0.000219	0.00119	CbGpPWpGaD
Nandrolone decanoate—Progesterone—ABCB1—ovarian cancer	0.000217	0.00876	CrCbGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—ovarian cancer	0.000214	0.00116	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.000214	0.00116	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYTB—ovarian cancer	0.000213	0.00116	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—KRAS—ovarian cancer	0.000211	0.00115	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000209	0.00113	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	0.000206	0.00112	CbGpPWpGaD
Nandrolone decanoate—Testosterone—ABCB1—ovarian cancer	0.000205	0.00828	CrCbGaD
Nandrolone decanoate—MAOB—Metabolism—YAP1—ovarian cancer	0.000204	0.00111	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—MYC—ovarian cancer	0.000197	0.00107	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	0.000195	0.00106	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—ovarian cancer	0.000193	0.00104	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—ovarian cancer	0.000193	0.00104	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—BRIP1—ovarian cancer	0.000191	0.00104	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PPP1CC—ovarian cancer	0.000191	0.00104	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	0.00019	0.00103	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—TP53—ovarian cancer	0.000188	0.00102	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—YAP1—ovarian cancer	0.000187	0.00101	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—BRIP1—ovarian cancer	0.000187	0.00101	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PPP1CC—ovarian cancer	0.000187	0.00101	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	0.000186	0.00101	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	0.000185	0.001	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—ovarian cancer	0.000182	0.000986	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—ESR1—ovarian cancer	0.000181	0.000981	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	0.000175	0.000949	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—IL6—ovarian cancer	0.000168	0.000908	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—FASN—ovarian cancer	0.000167	0.000903	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—SLC5A5—ovarian cancer	0.000164	0.000888	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—PGR—ovarian cancer	0.000163	0.000885	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—TP53—ovarian cancer	0.000162	0.000876	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	0.000161	0.000872	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	0.000159	0.00086	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—SLC2A1—ovarian cancer	0.000158	0.000858	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000158	0.000855	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	0.000156	0.000844	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—PARP1—ovarian cancer	0.000152	0.000822	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYP1B1—ovarian cancer	0.000152	0.000822	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—IL6—ovarian cancer	0.000148	0.000801	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	0.000137	0.00074	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000136	0.000737	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PPP2R1A—ovarian cancer	0.000135	0.000729	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	0.000132	0.000712	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—YAP1—ovarian cancer	0.000128	0.000695	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000127	0.000686	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—YAP1—ovarian cancer	0.000125	0.000678	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ABCB1—ovarian cancer	0.000125	0.000677	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000124	0.000671	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—PPP2R1A—ovarian cancer	0.000123	0.000667	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—TYMS—ovarian cancer	0.000123	0.000665	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—MAPK1—ovarian cancer	0.000121	0.000655	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000109	0.00059	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—FASN—ovarian cancer	0.000105	0.000567	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—SLC5A5—ovarian cancer	0.000103	0.000557	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—FASN—ovarian cancer	0.000102	0.000553	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—SLC5A5—ovarian cancer	0.0001	0.000544	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—SLC2A1—ovarian cancer	9.94e-05	0.000538	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CAV1—ovarian cancer	9.89e-05	0.000536	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—HRAS—ovarian cancer	9.7e-05	0.000526	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—SLC2A1—ovarian cancer	9.69e-05	0.000525	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP1B1—ovarian cancer	9.53e-05	0.000516	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	9.49e-05	0.000514	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—MYC—ovarian cancer	9.42e-05	0.00051	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP1B1—ovarian cancer	9.29e-05	0.000503	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PIK3CG—ovarian cancer	9.01e-05	0.000488	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—ESR1—ovarian cancer	8.72e-05	0.000472	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PPP2R1A—ovarian cancer	8.45e-05	0.000458	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PPP2R1A—ovarian cancer	8.24e-05	0.000446	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	8.2e-05	0.000444	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PIK3CD—ovarian cancer	7.92e-05	0.000429	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ABCB1—ovarian cancer	7.84e-05	0.000425	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—TYMS—ovarian cancer	7.7e-05	0.000417	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ABCB1—ovarian cancer	7.65e-05	0.000414	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—TYMS—ovarian cancer	7.51e-05	0.000407	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PIK3CB—ovarian cancer	6.9e-05	0.000374	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CAV1—ovarian cancer	6.21e-05	0.000336	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CAV1—ovarian cancer	6.05e-05	0.000328	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PTEN—ovarian cancer	5.97e-05	0.000323	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.78e-05	0.000313	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PIK3CG—ovarian cancer	5.65e-05	0.000306	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PIK3CG—ovarian cancer	5.52e-05	0.000299	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PIK3CD—ovarian cancer	4.97e-05	0.000269	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PIK3CD—ovarian cancer	4.85e-05	0.000263	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—MAPK3—ovarian cancer	4.66e-05	0.000253	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—MYC—ovarian cancer	4.54e-05	0.000246	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PIK3CB—ovarian cancer	4.33e-05	0.000235	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PIK3CB—ovarian cancer	4.23e-05	0.000229	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PIK3CA—ovarian cancer	4.21e-05	0.000228	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PTEN—ovarian cancer	3.74e-05	0.000203	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PTEN—ovarian cancer	3.65e-05	0.000198	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—AKT1—ovarian cancer	3.44e-05	0.000186	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—AKT1—ovarian cancer	3.15e-05	0.00017	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PIK3CA—ovarian cancer	2.64e-05	0.000143	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PIK3CA—ovarian cancer	2.58e-05	0.00014	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—AKT1—ovarian cancer	2.16e-05	0.000117	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—AKT1—ovarian cancer	2.1e-05	0.000114	CbGpPWpGaD
